Mobileye Global (MBLY) 10-Q9 Nov 232023 Q3 Quarterly reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2023	Nov. 02, 2023
Document and Entity Information
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2023
Entity File Number	001-41541
Entity Registrant Name	Mobileye Global Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	88-0666433
Entity Address, Address Line One	Har Hotzvim, 13 Hartom Street
Entity Address, Address Line Two	P.O. Box 45157
Entity Address, City or Town	Jerusalem
Entity Address, Country	IL
Entity Address, Postal Zip Code	9777513
City Area Code	972
Local Phone Number	2-541-7333
Title of 12(b) Security	Class A common stock, par value $0.01
Trading Symbol	MBLY
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		94,647,954
Entity Central Index Key	0001910139
Current Fiscal Year End Date	--12-30
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Millions		Sep. 30, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents		$ 1,193	$ 1,024
Trade accounts receivable, net		281	269
Inventories		354	113
Other current assets		80	110
Total current assets		1,908	1,516
Non-current assets
Property and equipment, net		426	384
Intangible assets, net		2,165	2,527
Goodwill		10,895	10,895
Other long-term assets		111	119
Total non-current assets		13,597	13,925
TOTAL ASSETS		15,505	15,441
Current liabilities
Accounts payable and accrued expenses		221	189
Employee related accrued expenses		79	88
Related party payable		44	73
Other current liabilities		47	34
Total current liabilities		391	384
Non-current liabilities
Long-term employee benefits		53	56
Deferred tax liabilities		149	162
Other long-term liabilities		39	45
Total non-current liabilities		241	263
TOTAL LIABILITIES		632	647
Equity
Additional paid-in capital		14,898	14,737
Accumulated other comprehensive income (loss)			(9)
Retained earnings (accumulated deficit)		(33)	57
TOTAL EQUITY	[1]	14,873	14,794
TOTAL LIABILITIES AND EQUITY		15,505	15,441
Class A common stock
Equity
Common stock		1	1
Class B common stock
Equity
Common stock		$ 7	$ 8

[1]Rounding of Class A and Class B share amounts due to Secondary offering.

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Common stock, par value	$ 0.01
Common stock, shares issued	100,000,000
Common stock, shares outstanding	100,000,000
Class A common stock
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	4,000,000,000	4,000,000,000
Common stock, shares issued	94,164,300	51,911,905
Common stock, shares outstanding	94,164,300	51,911,905
Class B common stock
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	1,500,000,000	1,500,000,000
Common stock, shares issued	711,500,000	750,000,000
Common stock, shares outstanding	711,500,000	750,000,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (UNAUDITED) - USD ($) shares in Millions, $ in Millions	3 Months Ended				9 Months Ended
	Sep. 30, 2023		Oct. 01, 2022		Sep. 30, 2023		Oct. 01, 2022
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (UNAUDITED)
Revenue	$ 530		$ 450		$ 1,442		$ 1,304
Cost of revenue	258		233		739		682
Gross profit	272		217		703		622
Research and development, net	218		206		664		565
Sales and marketing	28		27		90		91
General and administrative	18		9		55		27
Total operating expenses	264		242		809		683
Operating income (loss)	8		(25)		(106)		(61)
Interest income with related party			5				9
Interest expense with related party			(11)				(20)
Other financial income (expense), net	15		1		38		6
Income (loss) before income taxes	23		(30)		(68)		(66)
Benefit (provision) for income taxes	(6)		(15)		(22)		(46)
Net income (loss)	$ 17	[1]	$ (45)	[1]	$ (90)	[1]	$ (112)
Earnings (loss) per share attributed to Class A and Class B stockholders:
Basic	$ 0.02		$ (0.06)		$ (0.11)		$ (0.15)
Diluted	$ 0.02		$ (0.06)		$ (0.11)		$ (0.15)
Weighted-average number of shares used in computation of earnings (loss) per share attributed to Class A and Class B stockholders (in millions):
Basic	806		750		804		750
Diluted	810		750		804		750
Other comprehensive income (loss), net of tax			$ 6		$ 9		$ (23)
TOTAL COMPREHENSIVE INCOME (LOSS)	$ 17		$ (39)		$ (81)		$ (135)

[1]Rounding of Class A and Class B share amounts due to Secondary offering.

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) - USD ($) shares in Millions	Common Stock		Additional paid-in capital	Parent Net Investment	Accumulated Other Comprehensive Income (Loss)	Retained Earnings (Accumulated deficit)	Total	[1]
Beginning balance at Dec. 25, 2021	$ 0	[1]	$ 0	$ 15,884,000,000	$ 5,000,000	$ 0	$ 15,889,000,000
Net income (loss)	0	[1]	0	(112,000,000)	0	0	(112,000,000)
Tax sharing agreement with Parent	0	[1]	0	(16,000,000)	0	0	(16,000,000)
Other comprehensive income (loss), net	0	[1]	0	0	(23,000,000)	0	(23,000,000)
Equity transaction in connection with the legal purchase of Moovit entities	0	[1]	0	(900,000,000)	0	0	(900,000,000)
Dividend Note with related party	0	[1]	0	(3,500,000,000)	0	0	(3,500,000,000)
Dividend distribution	0	[1]	0	(336,000,000)	0	0	(336,000,000)
Net transfer from (to) Parent	$ 0	[1]	0	158,000,000	0	0	158,000,000
Ending balance (in shares) at Oct. 01, 2022	0
Ending balance at Oct. 01, 2022	$ 0	[1]	0	11,178,000,000	(18,000,000)	0	11,160,000,000
Beginning balance at Jul. 02, 2022	0	[1]	0	11,223,000,000	(24,000,000)	0	11,199,000,000
Net income (loss)	0	[1]	0	(45,000,000)	0	0	(45,000,000)
Tax sharing agreement with Parent	0	[1]	0	(9,000,000)	0	0	(9,000,000)
Other comprehensive income (loss), net	0	[1]	0	0	6,000,000	0	6,000,000
Net transfer from (to) Parent	$ 0	[1]	0	9,000,000	0	0	9,000,000
Ending balance (in shares) at Oct. 01, 2022	0
Ending balance at Oct. 01, 2022	$ 0	[1]	0	11,178,000,000	(18,000,000)	0	11,160,000,000
Beginning balance (in shares) at Dec. 31, 2022	802
Beginning balance at Dec. 31, 2022	$ 9,000,000	[1]	14,737,000,000	0	(9,000,000)	57,000,000	14,794,000,000
Net income (loss)	0	[1]	0	0	0	(90,000,000)	(90,000,000)
Share-based compensation expense	0	[1]	190,000,000	0	0	0	190,000,000
Recharge to Parent for Share-based compensation	0	[1]	(29,000,000)	0	0	0	(29,000,000)
Issuance of common stock under employee share-based compensation plans	$ 0	[1]	0	0	0	0	0
Issuance of common stock under employee share-based compensation plans (Shares)	4
Secondary offering			0	0	0	0
Other comprehensive income (loss), net	$ 0	[1]	0	0	9,000,000	0	9,000,000
Ending balance (in shares) at Sep. 30, 2023	806
Ending balance at Sep. 30, 2023	$ 8,000,000	[1]	14,898,000,000	0	0	(33,000,000)	14,873,000,000
Beginning balance (in shares) at Jul. 01, 2023	806
Beginning balance at Jul. 01, 2023	$ 8,000,000	[1]	14,842,000,000	0	0	(50,000,000)	14,800,000,000
Net income (loss)	0	[1]	0	0	0	17,000,000	17,000,000
Share-based compensation expense	0	[1]	63,000,000	0	0	0	63,000,000
Recharge to Parent for Share-based compensation	$ 0	[1]	(7,000,000)	0	0	0	(7,000,000)
Ending balance (in shares) at Sep. 30, 2023	806
Ending balance at Sep. 30, 2023	$ 8,000,000	[1]	$ 14,898,000,000	$ 0	$ 0	$ (33,000,000)	$ 14,873,000,000

[1]Rounding of Class A and Class B share amounts due to Secondary offering.

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2022		Sep. 30, 2023		Oct. 01, 2022		Oct. 01, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ (45)	[1]	$ (90)	[1]	$ (112)	[1]	$ (112)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation of property and equipment	7		24				17
Share-based compensation			190				112
Amortization of intangible assets	131		362				413
Exchange rate differences on cash and cash equivalents			9				6
Deferred income taxes			(13)				(8)
Interest on Dividend Note to related party, net							20
Interest with related party, net			16				20
Other			(1)				(3)
Changes in operating assets and liabilities:
Decrease (increase) in trade accounts receivable			6				(67)
Decrease (increase) in other current assets			16				28
Decrease (increase) in inventories			(241)				(8)
Increase (decrease) in accounts payable, accrued expenses and related party payable			21				22
Increase (decrease) in employee-related accrued expenses and long term benefits			(12)				(67)
Increase (decrease) in other current liabilities			(5)				10
Decrease (increase) in other long term assets			3				15
Increase (decrease) in long term liabilities							(3)
Net cash provided by operating activities			285				395
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment			(75)				(79)
Repayment of loan due from related party							734
Issuance of loan to related party							(336)
Net cash provided by (used in) investing activities			(75)				319
CASH FLOWS FROM FINANCING ACTIVITIES
Net transfers from Parent							99
Dividend paid							(336)
Share-based compensation recharge			(29)				(200)
Deferred offering costs							(14)
Net cash provided by (used in) financing activities			(29)				(451)
Effect of foreign exchange rate changes on cash and cash equivalents			(9)				(6)
Increase in cash, cash equivalents and restricted cash			172				257
Balance of cash, cash equivalents and restricted cash, at beginning of year			1,035
Balance of cash, cash equivalents and restricted cash, at end of period	882		1,207		882		882
Supplementary non-cash investing and financing activities:
Non-cash purchase of property and equipment			5				9
Non-cash share based compensation recharge							9
Equity transaction in connection with the legal purchase of Moovit entities							900
Dividend Note with related party					3,500	[1]	3,500
Non cash deferred offering costs	$ 1				$ 1		1
Tax sharing agreement with Parent							16
Supplemental cash flow information:
Cash received (paid) for income taxes, net of refunds			(45)				(40)
Interest received from related party			$ 16				$ 29

[1]Rounding of Class A and Class B share amounts due to Secondary offering.

GENERAL

GENERAL	9 Months Ended
GENERAL	Sep. 30, 2023
GENERAL
GENERAL	NOTE 1 - GENERAL Background Mobileye Global Inc. (“Mobileye”, “the Company” or “we”) is a leader in the development and deployment of advanced driver assistance systems (“ADAS”) and autonomous driving technologies and solutions, aimed to provide the capabilities required for the future of autonomous driving, leveraging a comprehensive suite of purpose-built software and hardware technologies. Mobileye combines the operations of its consolidated subsidiaries, which include the Mobileye Group, as defined below. Mobileye operates as a subsidiary of Intel Corporation (“Intel” or the “Parent”), which acquired a majority stake in Mobileye in August 2017 (the “Mobileye Acquisition”). The remaining issued and outstanding shares of Mobileye were acquired by Intel in 2018. Before the completion of the Mobileye IPO and the Reorganization (both as defined below) in October 2022, the Company consisted of the “Mobileye Group”, which combined the operations of Cyclops Holdings LLC (“Cyclops”), Mobileye B.V. and its subsidiaries, GG Acquisition Ltd. and Moovit App Global Ltd. and its subsidiaries (“Moovit”) and certain Intel employees mainly in research and development (the “Intel Aligned Groups”). The Mobileye IPO In December 2021, Intel announced plans to pursue an initial public offering of the Mobileye Group. In January 2022, Intel incorporated a new legal entity, Mobileye Global Inc., with the intent to contribute the Mobileye Group to Mobileye Global Inc. and to have Mobileye Global Inc. offer newly issued shares of common stock of Mobileye Global Inc. in an initial public offering. On October 28, 2022, the initial public offering of Mobileye (the “Mobileye IPO”) was completed and we issued 41,000,000 shares of our Class A common stock, at $21 per share, before underwriting discounts and commissions. Concurrently with the closing of the Mobileye IPO, the Company issued an additional 4,761,905 shares of its Class A common stock to General Atlantic (ME), L.P., a Delaware limited partnership, at $21 per share, pursuant to a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended, for gross proceeds of $100 million (the “Concurrent Private Placement”). On November 1, 2022, we closed the sale of an additional 6,150,000 Class A shares pursuant to the exercise of the underwriters’ over-allotment option. The Mobileye IPO generated proceeds to the Company of approximately $1.0 billion, including the proceeds from the underwriters exercise of their option and the Concurrent Private Placement, net of underwriting discounts and commissions in the amount of $41 million and offering costs in the amount of $18 million. Prior to the completion of the Mobileye IPO, we were a wholly-owned business of Intel Corporation. Upon the closing of the Mobileye IPO (after giving effect to the exercise of the underwriters’ over-allotment option), Intel continues to directly or indirectly hold all of the Class B common stock of Mobileye. Upon completion of the Mobileye IPO, we completed the legal entity reorganization (“Reorganization”) of the operations comprising the Mobileye Group business so that they are all under the single parent entity, Mobileye Global Inc., and the filing and effectiveness of our amended and restated certificate of incorporation. The Reorganization was accomplished through a series of transactions and agreements with Intel, including the legal purchase of 100% of the issued and outstanding equity interests of the Moovit entities from Intel. Secondary Offering On June 7, 2023, the Company announced the pricing of a public secondary offering of 38,500,000 shares of its Class A common stock (which shares were received upon the conversion of 38,500,000 shares of Class B common stock into Class A common stock) by Intel at a public offering price of $42.00 per share, which closed on June 12, 2023 (the “Secondary Offering”). The Company did not receive any proceeds from this offering. The Company paid the costs associated with the registration of shares in connection with the Secondary Offering in the amount of $1 million, other than underwriting discounts, fees and commissions. These costs were expensed as incurred within general and administrative expenses. Upon the completion of the Secondary Offering, Intel continues to directly or indirectly hold all of the Class B common stock of Mobileye, which represents approximately 88.3% of our outstanding common stock and 98.7% of the voting power of our common stock.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
SIGNIFICANT ACCOUNTING POLICIES	Sep. 30, 2023
SIGNIFICANT ACCOUNTING POLICIES
SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation These condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial reporting. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements have been prepared on the same basis as the Company’s annual audited consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for the fair statement of the Company’s financial information. We have a 52- or 53-week fiscal year that ends on the last Saturday in December. Fiscal year 2022 was a 53-week fiscal year; fiscal year 2023 is a 52-week fiscal year. The additional week in fiscal year 2022 was added in the first quarter, which consisted of 14 weeks. The results of operations for the three and nine months ended September 30, 2023 shown in this report are not necessarily indicative of the results to be expected for the full year ending 2023. The condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the fiscal year ended December 31, 2022. The financial statements and accompanying notes that include periods ending or as of dates prior to the completion of the Mobileye IPO have been derived from the consolidated financial statements and accounting records of Intel and are presented as if the Company had been operating as a stand-alone company. The assets, liabilities, revenue, and expenses directly attributable to the Company’s operations, including the acquired goodwill and intangible assets, have been reflected in these condensed consolidated financial statements on a historical cost basis, as included in the consolidated financial statements of Intel. As Mobileye Group was not historically held by a single legal entity, total parent net investment is shown in lieu of equity in the periods prior to the completion of the Mobileye IPO and represents Intel’s total interest in the recorded net assets of Mobileye Group. All intercompany transactions within the previously combined businesses of the Company have been eliminated. Transactions between the Company and Intel, arising from arrangements with Intel and other similar related-party transactions, were considered to be effectively settled at the time the transactions were recorded, unless otherwise noted. The total net effect of the settlement of these transactions was reflected within parent net investment as a component of equity and within net transfers from Parent as a financing activity in the periods prior to the completion of the Mobileye IPO, unless otherwise noted. Following the completion of the Mobileye IPO, the condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. There have been no material changes in our significant accounting policies as described in our consolidated financial statements for the fiscal year ended December 31, 2022. For further detail, see Note 2 in the audited consolidated financial statements for the fiscal year ended December 31, 2022. Use of estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts and events reported and disclosed in the condensed consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions and factors, including the current economic environment, that we believe to be reasonable under the circumstances. Actual results could differ from those estimates. On an on-going basis, management evaluates its estimates, judgments, and assumptions. The most significant estimates and assumptions relate to useful lives of intangible assets, impairment assessment of goodwill and income taxes. Cash, cash equivalents and restricted cash The following is a reconciliation of the cash, cash equivalents and restricted cash as of each period end: As of U.S. dollars in millions September 30, 2023 December 31, 2022 Cash $ 60 $ 188 Short term deposits 115 285 Money market funds 1,018 551 Restricted cash (within other current and other long-term assets) 14 11 Cash, cash equivalents and restricted cash $ 1,207 $ 1,035 Fair value measurement The carrying value of short term deposits classified as cash equivalents approximates their fair value due to the short maturity of these items. The Company’s investment in money market funds is measured at fair value and consists of financial assets for which quoted prices are available in an active market. Interest income related to money market funds for the three and nine months ended September 30, 2023 amounted to $15 million and $35 million, respectively. The carrying amounts of trade accounts receivable and accounts payable approximate fair value because of their generally short maturities. Research and development, net Research and development expenses are expensed as incurred, and consist primarily of personnel, facilities, equipment, and supplies for research and development activities. The Company occasionally enters into best-efforts nonrefundable, non-recurring engineering (“NRE”) arrangements pursuant to which the Company is reimbursed for a portion of the research and development expenses attributable to specific development programs. The Company does not receive any additional compensation or royalties upon completion of such projects and the potential customer does not commit to purchase the resulting product in the future. The participation reimbursement received by the Company does not depend on whether there are future benefits from the project. All intellectual property generated from these arrangements is exclusively owned by the Company. Participation in expenses for research and development projects are recognized on the basis of the costs incurred and are netted against research and development expenses in the condensed consolidated statements of operations and comprehensive income (loss). Research and development reimbursements of $24 million and $15 million were offset against research and development costs in the three months ended September 30, 2023 and October 1, 2022, respectively; and $57 million and $40 million were offset in the nine months ended September 30, 2023 and October 1, 2022, respectively. Derivatives and hedging Beginning in 2021, as part of Intel’s corporate hedging program, Intel hedges forecasted cash flows denominated in Israel Shekels (“ILS”) related to the Company. ILS is the largest operating expense currency of the Company. Intel combines all of its ILS exposures, and as part of Intel’s hedging program enters into hedging contracts to hedge Intel’s combined ILS exposure. Derivative gains and losses attributed to these condensed consolidated financial statements are recorded under accumulated other comprehensive income (loss) and reclassified into earnings in the same period or periods during which the hedged transaction affects the statement of operations. During the fourth quarter of 2022, the Company de-designated its remaining cash flow hedges for forecasted operating expenses denominated in ILS. As the hedged transactions and cash flows related to the outstanding instruments were expected to occur as originally forecasted, the associated gains and losses deferred in accumulated other comprehensive income (loss) on the Company’s consolidated balance sheet were reclassified into earnings in the same period or periods during which the originally hedged transactions affect earnings. Any subsequent changes in the fair value of the outstanding derivative instruments after the de-designation and termination of hedge accounting were immediately reflected in operating expenses. As of September 30, 2023, there are no outstanding hedging instruments and all of the related accumulated other comprehensive income (loss) was reclassified into the statement of operations and comprehensive income (loss). The notional amount and fair value of derivatives outstanding at Intel on behalf of Mobileye were: As of U.S. dollars in millions September 30, 2023 December 31, 2022 Notional amount of derivatives $ — $ 93 Fair value of derivatives receivable from (payable to) Intel $ — $ (9) The change in accumulated other comprehensive income (loss) relating to gains (losses) on derivatives used for hedging was as follows: Three Months Ended Nine Months Ended U.S. dollars in millions September 30, 2023 October 1, 2022 September 30, 2023 October 1, 2022 Other comprehensive income (loss) before reclassifications $ — $ 1 $ — $ (30) Amounts reclassified out of accumulated other comprehensive income (loss) — 6 10 6 Tax effects — (1) (1) 1 Other comprehensive income (loss), net $ — $ 6 $ 9 $ (23) Income Tax The provision for income tax consists of income taxes in the various jurisdictions where the Company is subject to taxation, primarily the United States and Israel. For interim periods, the Company recognizes an income tax benefit (provision) based on the estimated annual effective tax rate, calculated on a worldwide consolidated basis, expected for the entire year. The Company applies this rate to the year-to-date pre-tax income. The overall effective tax rate is influenced by valuation allowances on tax assets for which no benefit can be recognized due to the Company’s recent history of pretax losses sustained. Tax jurisdictions with forecasted pretax losses for the year for which no benefit can be recognized are excluded from the calculation of the worldwide estimated annual effective tax rate, and any associated tax expense or benefit for those jurisdictions is recorded separately. During the periods presented in the condensed consolidated financial statements, certain components of the Company’s business operations were included in the consolidated U.S. domestic income tax return filed by the Company’s Parent. The Company also files various foreign income tax returns on a separate basis, distinct from its Parent. The income tax provision included in the Company’s condensed consolidated financial statements has been calculated using the separate return method, as if the Company had filed its own tax returns. The Company has entered into a Tax Sharing Agreement with its Parent that establishes the amount of cash payable for the Company’s share of the tax liability owed on consolidated tax return filings with its Parent. Any differences between taxes payable to the Company’s Parent under the Tax Sharing Agreement and the current tax provision computed on a separate return basis, is reflected as adjustments to additional paid-in capital in the condensed consolidated statement of changes in equity and financing activities within the condensed consolidated statement of cash flows. The Company reflects tax loss and tax credit carry-forward attributes under the separate return method approach. Such tax attributes may not be benefited in the same period as the Company’s Parent on a consolidated tax return. Loss contingencies Management believes that there are no current matters that would have a material effect on the Company’s condensed consolidated balance sheets, statements of operations or cash flows. Legal fees are expensed as incurred. Concentration of credit risk Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash and cash equivalents, which include short-term deposits and money market funds, and also trade accounts receivable. The majority of the Company’s cash and cash equivalents are invested in banks domiciled in the U.S. and Europe, as well as in Israel. Generally, these cash equivalents may be redeemed upon demand. Short term bank deposits are held in the aforementioned banks. The money market funds consist of institutional investors money market funds and are readily redeemable to cash. Accordingly, management believes that these bank deposits and money market funds, have minimal credit risk. The Company’s accounts receivables are derived primarily from sales to Tier 1 suppliers to the automotive manufacturing industry located mainly in the U.S., Europe, and China. Concentration of credit risk with respect to accounts receivables is mitigated by credit limits, ongoing credit evaluation, and account monitoring procedures. Credit is granted based on an evaluation of a customer’s financial condition and, generally, collateral is not required. Trade accounts receivable are typically due from customers within 30 to 60 days. The Company performs ongoing credit evaluations of its customers and has not experienced any material losses in the periods presented. The Company establishes credit losses for accounts receivable by considering a number of factors, including the length of time accounts receivable are past due, the Company’s previous loss history from such customers, and the customers’ current ability to pay its obligation to the Company. As of September 30, 2023 and December 31, 2022, the credit losses for accounts receivable were not material. The Company writes off accounts receivable when they are deemed uncollectible. For the three and nine months ended September 30, 2023 and October 1, 2022, the charge-offs and recoveries in relation to the credit losses accounts were not material. Customer concentration risk The Company’s business, results of operations, and financial condition for the foreseeable future will likely continue to depend on sales to a relatively small number of customers. In the future, these customers may decide not to purchase the Company’s products, may purchase fewer products than in previous years, or may alter their purchasing patterns. Further, the amount of revenue attributable to any single customer or customer concentration generally may fluctuate in any given period. In addition, a decline in the production levels of one or more of the Company’s major customers, particularly with respect to vehicle models for which the Company is a significant supplier, could reduce revenue. The loss of one or more key customers, a reduction in sales to any key customer or the Company’s inability to attract new significant customers could negatively impact revenue and adversely affect the Company’s business, results of operations, and financial condition. See Note 9 related to customers that accounted for more than 10% of the Company’s total revenue and more than 10% of the total accounts receivable balance for each of the periods presented in these condensed consolidated financial statements. Dependence on a single supplier risk The Company purchases all its System on Chip (“EyeQ® SoC”) from a single supplier. Any issues that occur and persist in connection with the manufacture, delivery, quality, or cost of the assembly and testing of inventory could have a material adverse effect on the Company’s business, results of operations and financial condition. See below regarding a shortage in EyeQ® SoCs that the Company experienced during 2022 and may experience in the future, including in ECUs for SuperVision™ and other components for our products. Supply chain risk During the fiscal year ended December 31, 2022, due to global supply chain constraints and shortage of semiconductors, the Company’s sole supplier was not able to meet demand of the Company for EyeQ® SoCs, causing a significant reduction in the Company’s inventory levels. We may experience a shortfall of EyeQ® SoCs, ECUs for SuperVision™ and other components for our products. The reoccurrence of shortages and supply chain constraints in EyeQ® SoCs and ECUs for SuperVision™ and in components of our other products, may impair the Company’s ability to meet its customers’ requirements in a timely manner and may adversely affect the Company’s business, results of operations and financial condition. Moreover, to the extent that a global semiconductor shortage results in reduced production or production delays by automakers, those delays could result in reduced or delayed demand for the Company’s products. In addition, issues relating to the COVID-19 pandemic led to port congestion and intermittent supplier shutdowns and delays in the delivery of critical components, which resulted in additional expenses to expedite delivery of critical parts. Sustaining the Company’s production trajectory requires the readiness and solvency of its suppliers and vendors, a stable and motivated production workforce and ongoing government cooperation, including for travel and visa allowances, which governments may restrict. Although we cannot fully predict the length and the severity of the impact these pressures would have on a long-term basis, we do not anticipate that short-term supply chain constraints would materially adversely affect our results of operations, capital resources, sales, profits, and liquidity.

OTHER FINANCIAL STATEMENT DETAI

OTHER FINANCIAL STATEMENT DETAILS	9 Months Ended
OTHER FINANCIAL STATEMENT DETAILS	Sep. 30, 2023
OTHER FINANCIAL STATEMENT DETAILS
OTHER FINANCIAL STATEMENT DETAILS	NOTE 3 - OTHER FINANCIAL STATEMENT DETAILS Inventories: As of U.S. dollars in millions September 30, 2023 December 31, 2022 Raw materials $ 52 $ 41 Work in process 2 — Finished goods 300 72 Total inventories $ 354 $ 113 Inventory write-downs and write-offs were not material for the periods presented in these condensed consolidated financial statements. Property and equipment, net: As of U.S. dollars in millions September 30, 2023 December 31, 2022 Computers, electronic equipment and software $ 148 $ 124 Vehicles 14 13 Office furniture and equipment 4 4 Leasehold improvements 42 22 Construction in process 323 302 Total property and equipment, gross $ 531 $ 465 Less: accumulated depreciation (105) (81) Total property and equipment, net $ 426 $ 384 Depreciation expenses totaled $9 million and $7 million for the three months ended September 30, 2023 and October 1, 2022, respectively; and $24 million and $17 million for the nine months ended September 30, 2023 and October 1, 2022, respectively.

EQUITY

EQUITY	9 Months Ended
EQUITY	Sep. 30, 2023
EQUITY
EQUITY	NOTE 4 - EQUITY A. Mobileye Plan Following the Mobileye IPO in October 2022, the Company’s employees are incentivized and rewarded through the grant of the Company’s equity awards under the Mobileye Global Inc. 2022 Equity Incentive Plan (“the 2022 Plan”), which are granted for Class A shares and vest upon the satisfaction of a service-based vesting condition, mostly over service periods of three years. Restricted Stock Units The RSUs activity for the nine months ended September 30, 2023 for RSUs granted to Company’s employees under the 2022 Plan was as follows: Weighted average grant Number of RSUs date fair value In thousands U.S. dollars Outstanding as of December 31, 2022 12,564 $ 21.0 Granted 6,180 40.2 Vested (3,752) 21.0 Forfeited (230) 24.4 Outstanding as of September 30, 2023 14,762 $ 29.0 The RSUs activity for the three months ended September 30, 2023 for RSUs granted to Company’s employees under the 2022 Plan was as follows: Weighted average grant Number of RSUs date fair value In thousands U.S. dollars Options outstanding as of July 1, 2023 9,354 $ 22.2 Granted 5,524 40.4 Vested (2) 35.1 Forfeited (114) 26.7 Outstanding as of September 30, 2023 14,762 $ 29.0 As of September 30, 2023, the unrecognized compensation cost related to all unvested RSUs granted under the 2022 Plan, was $327 million, which is expected to be recognized as expense over a weighted-average period of 2.4 years. Intel Plan Prior to the Mobileye IPO, since 2017, employees of the Company had been incentivized and rewarded through the grant of Intel equity awards under Intel’s equity incentive plan which contains only a service condition. The equity awards granted generally vest over the course of three years from the grant date. Options Outstanding and exercisable options for Intel’s common stock under Intel’s plan as of September 30, 2023 were as follows: Outstanding Exercisable Weighted average Number of remaining Weighted average Number of Weighted average Exercise price options contractual life exercise price options exercise price U.S. dollars In thousands In years U.S. dollars In thousands U.S. dollars $ 4.0 - 21.6 59 2.3 $ 6.2 52 $ 4.1 $ 22.4 - 24.3 21 0.3 22.9 21 22.9 $55.2 68 5.5 55.2 68 55.2 Total 148 3.5 $ 30.9 141 $ 31.4 The option activity for the nine months ended September 30, 2023 for options granted to the Company’s employees for Intel’s common stock was as follows: Weighted average Weighted Aggregated Number of remaining average intrinsic options contractual Life exercise price value(1) In thousands In years U.S. dollars U.S. dollars in millions Options outstanding as of December 31, 2022 2,270 0.8 $ 27.1 $ 1 Exercised (23) — 22.2 — Expired (2,099) — 26.9 — Options outstanding as of September 30, 2023 148 3.5 $ 30.9 $ 2 Options exercisable as of September 30, 2023 141 3.6 $ 31.4 $ 2 The option activity for the three months ended September 30, 2023 for options granted to the Company’s employees for Intel’s common stock was as follows: Weighted average Weighted Aggregated Number of remaining average intrinsic options contractual Life exercise price value(1) In thousands In years U.S. dollars U.S. dollars in millions Options outstanding as of July 1, 2023 2,252 0.4 $ 27.1 $ 16 Exercised (5) — 21.9 — Expired (2,099) — 26.9 — Options outstanding as of September 30, 2023 148 3.5 $ 30.9 $ 2 Options exercisable as of September 30, 2023 141 3.6 $ 31.4 $ 2 (1) (2) RSUs The RSUs activity for the nine months ended September 30, 2023 for RSUs granted to the Company’s employees for Intel’s common stock was as follows: Weighted average Number of RSUs grant date fair value In thousands U.S. dollars Outstanding as of December 31, 2022 5,692 $ 44.8 Vested (881) 45.5 Forfeited (216) 45.7 Outstanding as of September 30, 2023 4,595 $ 44.6 The RSUs activity for the three months ended September 30, 2023 for RSUs granted to the Company’s employees for Intel’s common stock was as follows: Weighted average Number of RSUs grant date fair value In thousands U.S. dollars Outstanding as of July 1, 2023 4,848 $ 44.5 Vested (178) 40.7 Forfeited (75) 45.0 Outstanding as of September 30, 2023 4,595 $ 44.6 Unrecognized expenses As of September 30, 2023, the unrecognized compensation cost related to stock options and RSUs granted under the Intel 2006 Plan was $108 million, which will be recognized over a weighted average period of 1.1 years. Share-based compensation expense summary (for both Mobileye and Intel Plans) Share-based compensation expenses included in the condensed consolidated statements of operations and comprehensive income (loss) was as follows: Three months ended Nine months ended U.S. dollars in millions September 30, 2023 October 1, 2022 September 30, 2023 October 1, 2022 Cost of revenue $ — $ — $ 2 $ — Research and development, net 53 32 158 101 Sales and marketing 2 1 6 3 General and administrative 8 3 24 8 Total share-based compensation $ 63 $ 36 $ 190 $ 112

EARNINGS (LOSS) PER SHARE

EARNINGS (LOSS) PER SHARE	9 Months Ended
EARNINGS (LOSS) PER SHARE	Sep. 30, 2023
EARNINGS (LOSS) PER SHARE
EARNINGS (LOSS) PER SHARE	NOTE 5 - EARNINGS (LOSS) PER SHARE Before the Mobileye IPO, Intel held directly or indirectly the 100 shares of common stock of Mobileye, with a par value of $0.01 per share, that were issued and outstanding In connection with the Mobileye IPO, we issued 41,000,000 shares of our Class A common stock to the public at a public offering price of $21 per share and an additional 4,761,905 Class A shares at a private placement. The Mobileye IPO closed on October 28, 2022. On November 1, 2022, we closed the sale of an additional 6,150,000 shares pursuant to the exercise of the underwriters’ over-allotment option. In accordance with ASC 260, the Class A shares issued in connection with the Mobileye IPO are included in earnings (loss) per share calculations for periods subsequent to the closing of the Mobileye IPO and are not included in the earnings (loss) per share calculations for periods prior to the closing of the Mobileye IPO. On June 12, 2023, we completed the Secondary Offering, pursuant to which 38,500,000 shares of Class B common stock held by Intel were converted into an equal number of shares of Class A common stock. Accordingly, as of September 30, 2023, we have 711,500,000 Class B shares, all held by Intel, and 94,164,300 Class A shares, both of which are utilized for the calculation of basic and diluted EPS. The outstanding Class A shares also include shares issued upon vesting of outstanding RSUs, see note 4. For the three and nine months ended September 30, 2023, the computation of diluted earnings (loss) per share attributable to common stockholders does not include 5.5 million and 14.9 million potential common shares, respectively, related to restricted stock units granted under the 2022 Plan to the Company’s employees, as the effect of their inclusion would have been anti-dilutive. The following table summarizes the calculation of basic earnings (loss) per share for the periods presented: Three months ended Nine months ended September 30, October 1, September 30, October 1, In millions, except per share amounts 2023 2022 2023 2022 Numerator: Net income (loss) $ 17 $ (45) $ (90) $ (112) Denominator: Weighted average common shares - basic 806 750 804 750 Dilutive effect of unvested RSU awards 4 — — — Weighted average common shares - diluted 810 750 804 750 Earnings (loss) per share: Basic 0.02 (0.06) (0.11) (0.15) Diluted $ 0.02 $ (0.06) $ (0.11) $ (0.15)

INCOME TAXES

INCOME TAXES	9 Months Ended
INCOME TAXES	Sep. 30, 2023
INCOME TAXES
INCOME TAXES	NOTE 6 - INCOME TAXES The Company’s quarterly benefit (provision) for income taxes and the estimates of its annual effective tax rate, are subject to fluctuation due to several factors, principally including variability in overall pre-tax income and the mix of tax paying components to which such income relates. The income tax provision included in these condensed consolidated financial statements has been calculated using the separate return method, as if the Company had filed its own tax returns. Net operating losses generated by the Company that have been utilized as part of the Parent’s consolidated income tax return filings but have not been utilized by the Company under the separate return method approach, have been reflected in these condensed consolidated financial statements because the Company will recognize a benefit for the separate return method net operating losses when determined to be realizable, whether as a deduction against current taxable income in future periods or upon recognition of associated deferred tax assets based on valuation allowance assessments. Any differences between taxes currently payable to the Company’s Parent under the Tax Sharing Agreement and the current tax provision computed on a separate return basis, is reflected as adjustments to additional paid-in capital (see also Note 2). There was no adjustment to additional paid-in capital for the three and nine months ended September 30, 2023, based on estimates of forecasted 2023 US taxes payable under the separate return method for those periods. The adjustment to additional paid-in capital for the three and nine months ended October 1, 2022 was a decrease of $9 million and $16 million, respectively, because amounts payable under the Tax Sharing Agreement exceeded the amounts calculated under the separate return method. The tax expense for the nine months ended September 30, 2023 and October 1, 2022 was unfavorably impacted by a valuation allowance for certain jurisdictions. The decrease in tax expense was driven by a change in the jurisdictional composition of our taxable income based on operational results and the recognition of discrete tax items in 2022. Additionally, an accrued withholding tax expense of $14 million related to a dividend distribution between entities within the Mobileye Group that was recorded in the nine months ended October 1, 2022. As the Company has jurisdictions that have sustained recent losses based on the separate return method, a valuation allowance is required for deferred tax assets for which no benefit can be currently realized.

RELATED PARTIES TRANSACTIONS

RELATED PARTIES TRANSACTIONS	9 Months Ended
RELATED PARTIES TRANSACTIONS	Sep. 30, 2023
RELATED PARTIES TRANSACTIONS
RELATED PARTIES TRANSACTIONS	NOTE 7 - RELATED PARTIES TRANSACTIONS The Company has entered into a series of related party arrangements with Intel. For further description of the arrangements refer to Note 9 of the notes to consolidated financial statement for the year ended December 31, 2022. Stock Compensation Recharge Agreement The Company entered into a stock compensation recharge agreement with Intel, which requires the Company to reimburse Intel for certain amounts relating to the value of share-based compensation provided to the Company’s employees for RSUs or stock options exercisable in Intel stock. The liability associated with the stock compensation recharge agreement that is reflected on the condensed consolidated balance sheets, under related party payable was approximately $1 million and $1 million as of September 30, 2023 and December 31, 2022, respectively. The reimbursement amounts recorded as an adjustment to additional paid-in capital (and to parent net investment prior to the Mobileye IPO) in the condensed consolidated statement of changes in equity were $7 million and $5 million for the three months ended September 30, 2023 and October 1, 2022, respectively and $29 million and $45 million for the nine months ended September 30, 2023 and October 1, 2022, respectively. Lease agreements Under lease agreements with Intel, the Company leases office space in Intel’s buildings. The costs are included in the condensed consolidated statements of operations and comprehensive income (loss) primarily on a specific and direct attribution basis. The leasing costs for the three months ended September 30, 2023 and October 1, 2022, were $1.2 million and $1.3 million, respectively and $3.6 million and $2.0 million for the nine months ended September 30, 2023 and October 1, 2022, respectively. Other services to a related party The Company reimbursed its Chief Executive Officer for reasonable travel related expenses incurred while conducting business on behalf of the Company. Travel related reimbursements totaled $0.5 million and $0.5 million for the three months ended September 30, 2023 and October 1, 2022, respectively and $1.7 million and $0.8 million for the nine months ended September 30, 2023 and October 1, 2022, respectively. Administrative Services Agreement Under the Administrative Services Agreement, effective as of the completion of the Mobileye IPO, Intel provides the Company with administrative, financial, legal, tax, and other services. The Company pays fees to Intel for the services rendered based on pricing per service agreed between the Company and Intel. The costs incurred under this agreement for the three and nine months ended September 30, 2023 were $1.7 million and $2.9 million, respectively. Technology and Services Agreement The Technology and Services Agreement, effective as of the completion of the Mobileye IPO, provides a framework for the collaboration on technology projects and services between the Company and Intel (“Technology Projects”), and sets out the licenses granted by each party to its respective technology for the conduct of the Technology Projects, provisions relating to the ownership of certain existing technology, the allocation of rights in any new technology created in the course of the Technology Projects, and certain provisions applicable to the development of a certain radar product of the Company. The Technology and Services Agreement does not apply to projects for the development and manufacture of a Lidar sensor system for automobiles, for which the LiDAR Product Collaboration Agreement applies. Pursuant to the Technology and Services Agreement, the Company and Intel will agree to statements of work with additional terms for Technology Projects. The amount incurred under this agreement for the three and nine months ended September 30, 2023 were $1.4 million and $3.8 million, respectively. LiDAR Product Collaboration Agreement The LiDAR Product Collaboration Agreement, effective as of the completion of the Mobileye IPO, provides the terms that will apply to the Company’s collaboration with Intel for the development and manufacture of a Lidar sensor system for ADAS and AV in automobiles (“LiDAR Projects”). On some of the LiDAR programs joint funding will apply between Intel and Mobileye until the end of 2027 whereby Mobileye will bear its own Lidar sensor system development costs up to the first $40 million per year and Intel will bear up to $20 million per year of Mobileye’s Lidar sensor system development costs that are greater than $40 million per year. The LiDAR Product Collaboration Agreement further provides that Intel will manufacture certain components for the Company to market and sell as part of a FMCW (frequency-modulated continuous wave) Lidar sensor system solely for external environment sensing for ADAS and AV in automobiles. The price for the components Intel will manufacture for the Company will be based on a cost-plus model. In addition, the agreement also includes a profit-sharing model under which Mobileye will pay Intel a share of the gross profit for each LiDAR sensor system or components thereof, based on Intel technology, sold by Mobileye. There were no amounts received or receivable from Intel under this agreement for the three and nine months ended September 30, 2023. Tax Sharing Agreement The Tax Sharing Agreement establishes the respective rights, responsibilities and obligations of the Company and Intel after the completion of the Mobileye IPO with respect to tax matters, including the amount of cash the Company will pay to Intel for its share of the tax liability owed on the consolidated filings in which the Company or any of the Company’s subsidiaries are included, audit or other tax proceedings. As of September 30, 2023 and December 31, 2022, the related party payable to Intel, pursuant to the Tax Sharing Agreement was $34 million.

IDENTIFIED INTANGIBLE ASSETS

IDENTIFIED INTANGIBLE ASSETS	9 Months Ended
IDENTIFIED INTANGIBLE ASSETS	Sep. 30, 2023
IDENTIFIED INTANGIBLE ASSETS
IDENTIFIED INTANGIBLE ASSETS	NOTE 8 - IDENTIFIED INTANGIBLE ASSETS As of U.S. dollars in millions September 30, 2023 December 31, 2022 Accumulated Accumulated Gross Assets Amortization Net Gross Assets Amortization Net Developed technology $ 3,705 $ 1,913 $ 1,792 $ 3,973 $ 1,870 $ 2,103 Customer relationships & brands 786 413 373 786 362 424 Total $ 4,491 $ 2,326 $ 2,165 $ 4,759 $ 2,232 $ 2,527 The following table presents the amortization expenses recorded for these identified intangible assets and their weighted average useful lives: Three months ended Nine months ended Weighted September 30, October 1, September 30, October 1, Average U.S. dollars in millions 2023 2022 2023 2022 Useful Life Developed technology $ 94 $ 115 $ 311 $ 355 10 Customer relationships & brands 17 16 51 58 12 Total amortization expenses $ 111 $ 131 $ 362 $ 413 The Company expects future amortization expenses for the next five years and thereafter to be as follows: Remainder U.S. dollars in millions of 2023 2024 2025 2026 2027 Thereafter Total Future amortization expenses $ 112 $ 445 $ 443 $ 332 $ 179 $ 654 $ 2,165

SEGMENT INFORMATION

SEGMENT INFORMATION	9 Months Ended
SEGMENT INFORMATION	Sep. 30, 2023
SEGMENT INFORMATION
SEGMENT INFORMATION	NOTE 9 - SEGMENT INFORMATION An operating segment is defined as a component of an enterprise for which discrete financial information is available and is reviewed regularly by the Chief Operating Decision Maker (“CODM”), or decision-making group, to evaluate performance and make operating decisions. The Company has identified its CODM as the Chief Executive Officer (“CEO”). The Company’s organizational structure and management reporting supports two operating segments: Mobileye and Moovit. The CODM evaluates performance, makes operating decisions and allocates resources based on the financial data of these operating segments. Operating segments do not record inter-segment revenue. Mobileye is the Company’s only reportable operating segment and Moovit is presented within “Other” as per ASC 280, Segment Reporting. Segment performance is the operating income reported excluding the amortization of acquisition-related intangible assets. The measure of assets has not been disclosed for each segment as it is not regularly reviewed by the CODM. The accounting policies of the individual segments are the same as those described in the summary of significant accounting policies in Note 2 to the audited consolidated financial statements for the fiscal year ended December 31, 2022. The following are segment results for each period as follows: Three months ended September 30, 2023 Amounts not allocated to U.S. dollars in millions Mobileye Other segments Consolidated Revenues $ 521 $ 9 $ — $ 530 Cost of revenues 163 1 94 258 Research and development, net 208 10 — 218 Sales and marketing 8 3 17 28 General and administrative 15 3 — 18 Segment performance $ 127 $ (8) $ (111) $ 8 Other financial income (expense), net — — — 15 Income (loss) before taxes on income — — — 23 Share-based compensation 59 4 — 63 Depreciation of property and equipment 9 — — 9 Three months ended October 1, 2022 Amounts not allocated to U.S. dollars in millions Mobileye Other segments Consolidated Revenues $ 443 $ 7 $ — $ 450 Cost of revenues 117 1 115 233 Research and development, net 196 10 — 206 Sales and marketing 8 3 16 27 General and administrative 5 3 1 9 Segment performance $ 117 $ (10) $ (132) $ (25) Interest income (expense) with related party, net — — — (6) Other financial income (expense), net — — — 1 Income (loss) before taxes on income — — — (30) Share-based compensation 32 4 — 36 Depreciation of property and equipment 7 — — 7 Nine months ended September 30, 2023 Amounts not allocated to U.S. dollars in millions Mobileye Other segments Consolidated Revenues $ 1,417 $ 25 $ — $ 1,442 Cost of revenues 424 4 311 739 Research and development, net 633 31 — 664 Sales and marketing 30 9 51 90 General and administrative 47 8 — 55 Segment performance $ 283 $ (27) $ (362) $ (106) Other financial income (expense), net — — — 38 Income (loss) before taxes on income — — — (68) Share-based compensation 175 15 — 190 Depreciation of property and equipment 24 — — 24 Nine months ended October 1, 2022 Amounts not allocated to U.S. dollars in millions Mobileye Other segments Consolidated Revenues $ 1,286 $ 18 $ — $ 1,304 Cost of revenues 324 3 355 682 Research and development, net 534 31 — 565 Sales and marketing 24 9 58 91 General and administrative 14 9 4 27 Segment performance $ 390 $ (34) $ (417) $ (61) Interest income (expense) with related party, net — — — (11) Other financial income (expense), net — — — 6 Income (loss) before taxes on income — — — (66) Share-based compensation 101 11 — 112 Depreciation of property and equipment 17 — — 17 Total revenues based on the country that the product was shipped to were as follows: Three months ended Nine months ended September 30, October 1, September 30, October 1, U.S. dollars in millions 2023 2022 2023 2022 China 154 126 423 360 USA 122 113 295 342 Germany 98 72 267 174 South Korea 37 31 118 86 United Kingdom 31 52 108 165 Poland 22 14 64 58 Czech Republic 11 — 41 — Hungary 30 25 64 62 Rest of World 25 17 62 57 Total $ 530 $ 450 $ 1,442 $ 1,304 We generate the majority of our revenue from the sale of our EyeQ® SoCs to OEMs through sales to Tier 1 automotive suppliers. EyeQ® SoC sales represented approximately 89% and 88% of our revenue for each of the three months ended September 30, 2023 and October 1, 2022, respectively and 90% and 90% of our revenue for each of the nine months ended September 30, 2023 and October 1, 2022, respectively. Major Customers Revenue from major customers that amount to 10% or more of total revenue: Three months ended Nine months ended September 30, October 1, September 30, October 1, 2023 2022 2023 2022 Percent of total revenues: Customer A 27 % 31 % 28 % 39 % Customer B 26 % 19 % 26 % 17 % Customer C 15 % 16 % 14 % 15 % Accounts receivable balances of major customers that amount to 10% or more of total accounts receivable balance: As of September 30, December 31, 2023 2022 Percent of total accounts receivables balance: Customer A 32 % 32 % Customer B 16 % 19 % Customer C 22 % 25 %

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
SUBSEQUENT EVENTS	Sep. 30, 2023
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 10 - SUBSEQUENT EVENTS In October 2023, the Company’s compensation committee approved the issuance of restricted stock units to be issued under our 2022 Equity Incentive Plan. The total aggregate fair value of RSUs granted was $20.8 million, which consisted of 582 thousand RSUs, which will vest over a service period of three years.

SIGNIFICANT ACCOUNTING POLICI_2

SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
SIGNIFICANT ACCOUNTING POLICIES (Policies)	Sep. 30, 2023
SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	Basis of Presentation These condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial reporting. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements have been prepared on the same basis as the Company’s annual audited consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for the fair statement of the Company’s financial information. We have a 52- or 53-week fiscal year that ends on the last Saturday in December. Fiscal year 2022 was a 53-week fiscal year; fiscal year 2023 is a 52-week fiscal year. The additional week in fiscal year 2022 was added in the first quarter, which consisted of 14 weeks. The results of operations for the three and nine months ended September 30, 2023 shown in this report are not necessarily indicative of the results to be expected for the full year ending 2023. The condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the fiscal year ended December 31, 2022. The financial statements and accompanying notes that include periods ending or as of dates prior to the completion of the Mobileye IPO have been derived from the consolidated financial statements and accounting records of Intel and are presented as if the Company had been operating as a stand-alone company. The assets, liabilities, revenue, and expenses directly attributable to the Company’s operations, including the acquired goodwill and intangible assets, have been reflected in these condensed consolidated financial statements on a historical cost basis, as included in the consolidated financial statements of Intel. As Mobileye Group was not historically held by a single legal entity, total parent net investment is shown in lieu of equity in the periods prior to the completion of the Mobileye IPO and represents Intel’s total interest in the recorded net assets of Mobileye Group. All intercompany transactions within the previously combined businesses of the Company have been eliminated. Transactions between the Company and Intel, arising from arrangements with Intel and other similar related-party transactions, were considered to be effectively settled at the time the transactions were recorded, unless otherwise noted. The total net effect of the settlement of these transactions was reflected within parent net investment as a component of equity and within net transfers from Parent as a financing activity in the periods prior to the completion of the Mobileye IPO, unless otherwise noted. Following the completion of the Mobileye IPO, the condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. There have been no material changes in our significant accounting policies as described in our consolidated financial statements for the fiscal year ended December 31, 2022. For further detail, see Note 2 in the audited consolidated financial statements for the fiscal year ended December 31, 2022.
Use of estimates	Use of estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts and events reported and disclosed in the condensed consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions and factors, including the current economic environment, that we believe to be reasonable under the circumstances. Actual results could differ from those estimates. On an on-going basis, management evaluates its estimates, judgments, and assumptions. The most significant estimates and assumptions relate to useful lives of intangible assets, impairment assessment of goodwill and income taxes.
Cash, cash equivalents and restricted cash	Cash, cash equivalents and restricted cash The following is a reconciliation of the cash, cash equivalents and restricted cash as of each period end: As of U.S. dollars in millions September 30, 2023 December 31, 2022 Cash $ 60 $ 188 Short term deposits 115 285 Money market funds 1,018 551 Restricted cash (within other current and other long-term assets) 14 11 Cash, cash equivalents and restricted cash $ 1,207 $ 1,035
Fair value measurement	Fair value measurement The carrying value of short term deposits classified as cash equivalents approximates their fair value due to the short maturity of these items. The Company’s investment in money market funds is measured at fair value and consists of financial assets for which quoted prices are available in an active market. Interest income related to money market funds for the three and nine months ended September 30, 2023 amounted to $15 million and $35 million, respectively. The carrying amounts of trade accounts receivable and accounts payable approximate fair value because of their generally short maturities.
Research and development, net	Research and development, net Research and development expenses are expensed as incurred, and consist primarily of personnel, facilities, equipment, and supplies for research and development activities. The Company occasionally enters into best-efforts nonrefundable, non-recurring engineering (“NRE”) arrangements pursuant to which the Company is reimbursed for a portion of the research and development expenses attributable to specific development programs. The Company does not receive any additional compensation or royalties upon completion of such projects and the potential customer does not commit to purchase the resulting product in the future. The participation reimbursement received by the Company does not depend on whether there are future benefits from the project. All intellectual property generated from these arrangements is exclusively owned by the Company. Participation in expenses for research and development projects are recognized on the basis of the costs incurred and are netted against research and development expenses in the condensed consolidated statements of operations and comprehensive income (loss). Research and development reimbursements of $24 million and $15 million were offset against research and development costs in the three months ended September 30, 2023 and October 1, 2022, respectively; and $57 million and $40 million were offset in the nine months ended September 30, 2023 and October 1, 2022, respectively.
Derivatives and hedging	Derivatives and hedging Beginning in 2021, as part of Intel’s corporate hedging program, Intel hedges forecasted cash flows denominated in Israel Shekels (“ILS”) related to the Company. ILS is the largest operating expense currency of the Company. Intel combines all of its ILS exposures, and as part of Intel’s hedging program enters into hedging contracts to hedge Intel’s combined ILS exposure. Derivative gains and losses attributed to these condensed consolidated financial statements are recorded under accumulated other comprehensive income (loss) and reclassified into earnings in the same period or periods during which the hedged transaction affects the statement of operations. During the fourth quarter of 2022, the Company de-designated its remaining cash flow hedges for forecasted operating expenses denominated in ILS. As the hedged transactions and cash flows related to the outstanding instruments were expected to occur as originally forecasted, the associated gains and losses deferred in accumulated other comprehensive income (loss) on the Company’s consolidated balance sheet were reclassified into earnings in the same period or periods during which the originally hedged transactions affect earnings. Any subsequent changes in the fair value of the outstanding derivative instruments after the de-designation and termination of hedge accounting were immediately reflected in operating expenses. As of September 30, 2023, there are no outstanding hedging instruments and all of the related accumulated other comprehensive income (loss) was reclassified into the statement of operations and comprehensive income (loss). The notional amount and fair value of derivatives outstanding at Intel on behalf of Mobileye were: As of U.S. dollars in millions September 30, 2023 December 31, 2022 Notional amount of derivatives $ — $ 93 Fair value of derivatives receivable from (payable to) Intel $ — $ (9) The change in accumulated other comprehensive income (loss) relating to gains (losses) on derivatives used for hedging was as follows: Three Months Ended Nine Months Ended U.S. dollars in millions September 30, 2023 October 1, 2022 September 30, 2023 October 1, 2022 Other comprehensive income (loss) before reclassifications $ — $ 1 $ — $ (30) Amounts reclassified out of accumulated other comprehensive income (loss) — 6 10 6 Tax effects — (1) (1) 1 Other comprehensive income (loss), net $ — $ 6 $ 9 $ (23)
Income Tax	Income Tax The provision for income tax consists of income taxes in the various jurisdictions where the Company is subject to taxation, primarily the United States and Israel. For interim periods, the Company recognizes an income tax benefit (provision) based on the estimated annual effective tax rate, calculated on a worldwide consolidated basis, expected for the entire year. The Company applies this rate to the year-to-date pre-tax income. The overall effective tax rate is influenced by valuation allowances on tax assets for which no benefit can be recognized due to the Company’s recent history of pretax losses sustained. Tax jurisdictions with forecasted pretax losses for the year for which no benefit can be recognized are excluded from the calculation of the worldwide estimated annual effective tax rate, and any associated tax expense or benefit for those jurisdictions is recorded separately. During the periods presented in the condensed consolidated financial statements, certain components of the Company’s business operations were included in the consolidated U.S. domestic income tax return filed by the Company’s Parent. The Company also files various foreign income tax returns on a separate basis, distinct from its Parent. The income tax provision included in the Company’s condensed consolidated financial statements has been calculated using the separate return method, as if the Company had filed its own tax returns. The Company has entered into a Tax Sharing Agreement with its Parent that establishes the amount of cash payable for the Company’s share of the tax liability owed on consolidated tax return filings with its Parent. Any differences between taxes payable to the Company’s Parent under the Tax Sharing Agreement and the current tax provision computed on a separate return basis, is reflected as adjustments to additional paid-in capital in the condensed consolidated statement of changes in equity and financing activities within the condensed consolidated statement of cash flows. The Company reflects tax loss and tax credit carry-forward attributes under the separate return method approach. Such tax attributes may not be benefited in the same period as the Company’s Parent on a consolidated tax return.
Loss contingencies	Loss contingencies Management believes that there are no current matters that would have a material effect on the Company’s condensed consolidated balance sheets, statements of operations or cash flows. Legal fees are expensed as incurred.
Concentration of credit risk	Concentration of credit risk Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash and cash equivalents, which include short-term deposits and money market funds, and also trade accounts receivable. The majority of the Company’s cash and cash equivalents are invested in banks domiciled in the U.S. and Europe, as well as in Israel. Generally, these cash equivalents may be redeemed upon demand. Short term bank deposits are held in the aforementioned banks. The money market funds consist of institutional investors money market funds and are readily redeemable to cash. Accordingly, management believes that these bank deposits and money market funds, have minimal credit risk. The Company’s accounts receivables are derived primarily from sales to Tier 1 suppliers to the automotive manufacturing industry located mainly in the U.S., Europe, and China. Concentration of credit risk with respect to accounts receivables is mitigated by credit limits, ongoing credit evaluation, and account monitoring procedures. Credit is granted based on an evaluation of a customer’s financial condition and, generally, collateral is not required. Trade accounts receivable are typically due from customers within 30 to 60 days. The Company performs ongoing credit evaluations of its customers and has not experienced any material losses in the periods presented. The Company establishes credit losses for accounts receivable by considering a number of factors, including the length of time accounts receivable are past due, the Company’s previous loss history from such customers, and the customers’ current ability to pay its obligation to the Company. As of September 30, 2023 and December 31, 2022, the credit losses for accounts receivable were not material. The Company writes off accounts receivable when they are deemed uncollectible. For the three and nine months ended September 30, 2023 and October 1, 2022, the charge-offs and recoveries in relation to the credit losses accounts were not material.
Customer concentration risk	Customer concentration risk The Company’s business, results of operations, and financial condition for the foreseeable future will likely continue to depend on sales to a relatively small number of customers. In the future, these customers may decide not to purchase the Company’s products, may purchase fewer products than in previous years, or may alter their purchasing patterns. Further, the amount of revenue attributable to any single customer or customer concentration generally may fluctuate in any given period. In addition, a decline in the production levels of one or more of the Company’s major customers, particularly with respect to vehicle models for which the Company is a significant supplier, could reduce revenue. The loss of one or more key customers, a reduction in sales to any key customer or the Company’s inability to attract new significant customers could negatively impact revenue and adversely affect the Company’s business, results of operations, and financial condition. See Note 9 related to customers that accounted for more than 10% of the Company’s total revenue and more than 10% of the total accounts receivable balance for each of the periods presented in these condensed consolidated financial statements.
Dependence on a single supplier risk	Dependence on a single supplier risk The Company purchases all its System on Chip (“EyeQ® SoC”) from a single supplier. Any issues that occur and persist in connection with the manufacture, delivery, quality, or cost of the assembly and testing of inventory could have a material adverse effect on the Company’s business, results of operations and financial condition. See below regarding a shortage in EyeQ® SoCs that the Company experienced during 2022 and may experience in the future, including in ECUs for SuperVision™ and other components for our products.
Supply chain risk	Supply chain risk During the fiscal year ended December 31, 2022, due to global supply chain constraints and shortage of semiconductors, the Company’s sole supplier was not able to meet demand of the Company for EyeQ® SoCs, causing a significant reduction in the Company’s inventory levels. We may experience a shortfall of EyeQ® SoCs, ECUs for SuperVision™ and other components for our products. The reoccurrence of shortages and supply chain constraints in EyeQ® SoCs and ECUs for SuperVision™ and in components of our other products, may impair the Company’s ability to meet its customers’ requirements in a timely manner and may adversely affect the Company’s business, results of operations and financial condition. Moreover, to the extent that a global semiconductor shortage results in reduced production or production delays by automakers, those delays could result in reduced or delayed demand for the Company’s products. In addition, issues relating to the COVID-19 pandemic led to port congestion and intermittent supplier shutdowns and delays in the delivery of critical components, which resulted in additional expenses to expedite delivery of critical parts. Sustaining the Company’s production trajectory requires the readiness and solvency of its suppliers and vendors, a stable and motivated production workforce and ongoing government cooperation, including for travel and visa allowances, which governments may restrict. Although we cannot fully predict the length and the severity of the impact these pressures would have on a long-term basis, we do not anticipate that short-term supply chain constraints would materially adversely affect our results of operations, capital resources, sales, profits, and liquidity.

SIGNIFICANT ACCOUNTING POLICI_3

SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
SIGNIFICANT ACCOUNTING POLICIES (Tables)	Sep. 30, 2023
SIGNIFICANT ACCOUNTING POLICIES
Schedule of reconciliation of cash, cash equivalents and restricted cash	As of U.S. dollars in millions September 30, 2023 December 31, 2022 Cash $ 60 $ 188 Short term deposits 115 285 Money market funds 1,018 551 Restricted cash (within other current and other long-term assets) 14 11 Cash, cash equivalents and restricted cash $ 1,207 $ 1,035
Schedule of notional amount and fair value of derivatives outstanding at Intel on behalf of Mobileye	As of U.S. dollars in millions September 30, 2023 December 31, 2022 Notional amount of derivatives $ — $ 93 Fair value of derivatives receivable from (payable to) Intel $ — $ (9)
Schedule of change in accumulated other comprehensive income (loss) relating to gains (losses) on derivatives used for hedging	Three Months Ended Nine Months Ended U.S. dollars in millions September 30, 2023 October 1, 2022 September 30, 2023 October 1, 2022 Other comprehensive income (loss) before reclassifications $ — $ 1 $ — $ (30) Amounts reclassified out of accumulated other comprehensive income (loss) — 6 10 6 Tax effects — (1) (1) 1 Other comprehensive income (loss), net $ — $ 6 $ 9 $ (23)

OTHER FINANCIAL STATEMENT DET_2

OTHER FINANCIAL STATEMENT DETAILS (Tables)	9 Months Ended
OTHER FINANCIAL STATEMENT DETAILS (Tables)	Sep. 30, 2023
OTHER FINANCIAL STATEMENT DETAILS
Schedule of inventories	As of U.S. dollars in millions September 30, 2023 December 31, 2022 Raw materials $ 52 $ 41 Work in process 2 — Finished goods 300 72 Total inventories $ 354 $ 113
Schedule of property and equipment, net	As of U.S. dollars in millions September 30, 2023 December 31, 2022 Computers, electronic equipment and software $ 148 $ 124 Vehicles 14 13 Office furniture and equipment 4 4 Leasehold improvements 42 22 Construction in process 323 302 Total property and equipment, gross $ 531 $ 465 Less: accumulated depreciation (105) (81) Total property and equipment, net $ 426 $ 384

EQUITY (Tables)

EQUITY (Tables)	9 Months Ended
EQUITY (Tables)	Sep. 30, 2023
EQUITY
Schedule of RSUs activity	Weighted average grant Number of RSUs date fair value In thousands U.S. dollars Outstanding as of December 31, 2022 12,564 $ 21.0 Granted 6,180 40.2 Vested (3,752) 21.0 Forfeited (230) 24.4 Outstanding as of September 30, 2023 14,762 $ 29.0 Weighted average grant Number of RSUs date fair value In thousands U.S. dollars Options outstanding as of July 1, 2023 9,354 $ 22.2 Granted 5,524 40.4 Vested (2) 35.1 Forfeited (114) 26.7 Outstanding as of September 30, 2023 14,762 $ 29.0
Schedule of outstanding and exercisable options	Outstanding and exercisable options for Intel’s common stock under Intel’s plan as of September 30, 2023 were as follows: Outstanding Exercisable Weighted average Number of remaining Weighted average Number of Weighted average Exercise price options contractual life exercise price options exercise price U.S. dollars In thousands In years U.S. dollars In thousands U.S. dollars $ 4.0 - 21.6 59 2.3 $ 6.2 52 $ 4.1 $ 22.4 - 24.3 21 0.3 22.9 21 22.9 $55.2 68 5.5 55.2 68 55.2 Total 148 3.5 $ 30.9 141 $ 31.4
Schedule of option activity	Weighted average Weighted Aggregated Number of remaining average intrinsic options contractual Life exercise price value(1) In thousands In years U.S. dollars U.S. dollars in millions Options outstanding as of December 31, 2022 2,270 0.8 $ 27.1 $ 1 Exercised (23) — 22.2 — Expired (2,099) — 26.9 — Options outstanding as of September 30, 2023 148 3.5 $ 30.9 $ 2 Options exercisable as of September 30, 2023 141 3.6 $ 31.4 $ 2 Weighted average Weighted Aggregated Number of remaining average intrinsic options contractual Life exercise price value(1) In thousands In years U.S. dollars U.S. dollars in millions Options outstanding as of July 1, 2023 2,252 0.4 $ 27.1 $ 16 Exercised (5) — 21.9 — Expired (2,099) — 26.9 — Options outstanding as of September 30, 2023 148 3.5 $ 30.9 $ 2 Options exercisable as of September 30, 2023 141 3.6 $ 31.4 $ 2 (1) (2)
Schedule of share-based compensation expenses	Three months ended Nine months ended U.S. dollars in millions September 30, 2023 October 1, 2022 September 30, 2023 October 1, 2022 Cost of revenue $ — $ — $ 2 $ — Research and development, net 53 32 158 101 Sales and marketing 2 1 6 3 General and administrative 8 3 24 8 Total share-based compensation $ 63 $ 36 $ 190 $ 112
Intel
EQUITY
Schedule of RSUs activity	The RSUs activity for the nine months ended September 30, 2023 for RSUs granted to the Company’s employees for Intel’s common stock was as follows: Weighted average Number of RSUs grant date fair value In thousands U.S. dollars Outstanding as of December 31, 2022 5,692 $ 44.8 Vested (881) 45.5 Forfeited (216) 45.7 Outstanding as of September 30, 2023 4,595 $ 44.6 The RSUs activity for the three months ended September 30, 2023 for RSUs granted to the Company’s employees for Intel’s common stock was as follows: Weighted average Number of RSUs grant date fair value In thousands U.S. dollars Outstanding as of July 1, 2023 4,848 $ 44.5 Vested (178) 40.7 Forfeited (75) 45.0 Outstanding as of September 30, 2023 4,595 $ 44.6

EARNINGS (LOSS) PER SHARE (Tabl

EARNINGS (LOSS) PER SHARE (Tables)	9 Months Ended
EARNINGS (LOSS) PER SHARE (Tables)	Sep. 30, 2023
EARNINGS (LOSS) PER SHARE
Schedule of calculation of basic earnings (loss) per share	Three months ended Nine months ended September 30, October 1, September 30, October 1, In millions, except per share amounts 2023 2022 2023 2022 Numerator: Net income (loss) $ 17 $ (45) $ (90) $ (112) Denominator: Weighted average common shares - basic 806 750 804 750 Dilutive effect of unvested RSU awards 4 — — — Weighted average common shares - diluted 810 750 804 750 Earnings (loss) per share: Basic 0.02 (0.06) (0.11) (0.15) Diluted $ 0.02 $ (0.06) $ (0.11) $ (0.15)

IDENTIFIED INTANGIBLE ASSETS (T

IDENTIFIED INTANGIBLE ASSETS (Tables)	9 Months Ended
IDENTIFIED INTANGIBLE ASSETS (Tables)	Sep. 30, 2023
IDENTIFIED INTANGIBLE ASSETS
Schedule of components of identified intangible assets	As of U.S. dollars in millions September 30, 2023 December 31, 2022 Accumulated Accumulated Gross Assets Amortization Net Gross Assets Amortization Net Developed technology $ 3,705 $ 1,913 $ 1,792 $ 3,973 $ 1,870 $ 2,103 Customer relationships & brands 786 413 373 786 362 424 Total $ 4,491 $ 2,326 $ 2,165 $ 4,759 $ 2,232 $ 2,527
Schedule of amortization expenses recorded for these identified intangible assets and their weighted average useful lives	Three months ended Nine months ended Weighted September 30, October 1, September 30, October 1, Average U.S. dollars in millions 2023 2022 2023 2022 Useful Life Developed technology $ 94 $ 115 $ 311 $ 355 10 Customer relationships & brands 17 16 51 58 12 Total amortization expenses $ 111 $ 131 $ 362 $ 413
Schedule of expected future amortization expenses for the next five years	Remainder U.S. dollars in millions of 2023 2024 2025 2026 2027 Thereafter Total Future amortization expenses $ 112 $ 445 $ 443 $ 332 $ 179 $ 654 $ 2,165

SEGMENT INFORMATION (Tables)

SEGMENT INFORMATION (Tables)	9 Months Ended
SEGMENT INFORMATION (Tables)	Sep. 30, 2023
SEGMENT INFORMATION
Schedule of segment results	Three months ended September 30, 2023 Amounts not allocated to U.S. dollars in millions Mobileye Other segments Consolidated Revenues $ 521 $ 9 $ — $ 530 Cost of revenues 163 1 94 258 Research and development, net 208 10 — 218 Sales and marketing 8 3 17 28 General and administrative 15 3 — 18 Segment performance $ 127 $ (8) $ (111) $ 8 Other financial income (expense), net — — — 15 Income (loss) before taxes on income — — — 23 Share-based compensation 59 4 — 63 Depreciation of property and equipment 9 — — 9 Three months ended October 1, 2022 Amounts not allocated to U.S. dollars in millions Mobileye Other segments Consolidated Revenues $ 443 $ 7 $ — $ 450 Cost of revenues 117 1 115 233 Research and development, net 196 10 — 206 Sales and marketing 8 3 16 27 General and administrative 5 3 1 9 Segment performance $ 117 $ (10) $ (132) $ (25) Interest income (expense) with related party, net — — — (6) Other financial income (expense), net — — — 1 Income (loss) before taxes on income — — — (30) Share-based compensation 32 4 — 36 Depreciation of property and equipment 7 — — 7 Nine months ended September 30, 2023 Amounts not allocated to U.S. dollars in millions Mobileye Other segments Consolidated Revenues $ 1,417 $ 25 $ — $ 1,442 Cost of revenues 424 4 311 739 Research and development, net 633 31 — 664 Sales and marketing 30 9 51 90 General and administrative 47 8 — 55 Segment performance $ 283 $ (27) $ (362) $ (106) Other financial income (expense), net — — — 38 Income (loss) before taxes on income — — — (68) Share-based compensation 175 15 — 190 Depreciation of property and equipment 24 — — 24 Nine months ended October 1, 2022 Amounts not allocated to U.S. dollars in millions Mobileye Other segments Consolidated Revenues $ 1,286 $ 18 $ — $ 1,304 Cost of revenues 324 3 355 682 Research and development, net 534 31 — 565 Sales and marketing 24 9 58 91 General and administrative 14 9 4 27 Segment performance $ 390 $ (34) $ (417) $ (61) Interest income (expense) with related party, net — — — (11) Other financial income (expense), net — — — 6 Income (loss) before taxes on income — — — (66) Share-based compensation 101 11 — 112 Depreciation of property and equipment 17 — — 17
Schedule of total revenues based on country	Three months ended Nine months ended September 30, October 1, September 30, October 1, U.S. dollars in millions 2023 2022 2023 2022 China 154 126 423 360 USA 122 113 295 342 Germany 98 72 267 174 South Korea 37 31 118 86 United Kingdom 31 52 108 165 Poland 22 14 64 58 Czech Republic 11 — 41 — Hungary 30 25 64 62 Rest of World 25 17 62 57 Total $ 530 $ 450 $ 1,442 $ 1,304
Schedule of concentration of risk	Three months ended Nine months ended September 30, October 1, September 30, October 1, 2023 2022 2023 2022 Percent of total revenues: Customer A 27 % 31 % 28 % 39 % Customer B 26 % 19 % 26 % 17 % Customer C 15 % 16 % 14 % 15 % As of September 30, December 31, 2023 2022 Percent of total accounts receivables balance: Customer A 32 % 32 % Customer B 16 % 19 % Customer C 22 % 25 %

GENERAL (Details)

GENERAL (Details) - USD ($) $ / shares in Units, $ in Millions	Jun. 12, 2023	Jun. 07, 2023	Nov. 01, 2022	Oct. 28, 2022	May 31, 2022
GENERAL
Amount of secondary offering		$ 1
Class A
GENERAL
Number of shares issued during the period			6,150,000
Class B
GENERAL
Number of shares converted into Class A common stock	38,500,000
IPO
GENERAL
Net proceeds from IPO				$ 1,000
Underwriting discounts and commissions				41
Offering costs				$ 18
IPO \| Class A
GENERAL
Number of shares issued during the period				41,000,000
Offering price per share				$ 21
Private placement
GENERAL
Gross proceeds from private placement				$ 100
Private placement \| Class A
GENERAL
Number of shares issued during the period				4,761,905
Offering price per share				$ 21
Secondary Offering \| Class A
GENERAL
Number of shares issued during the period		38,500,000
Offering price per share		$ 42
Secondary Offering \| Class B
GENERAL
Number of shares converted into Class A common stock		38,500,000
Moovit
GENERAL
Equity interests percentage					100%
Intel
GENERAL
Percentage of voting power of common stock		98.70%
Intel \| Secondary Offering
GENERAL
Percentage of outstanding common stock		88.30%

SIGNIFICANT ACCOUNTING POLICI_4

SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022
SIGNIFICANT ACCOUNTING POLICIES
Interest income related to money market funds	$ 15		$ 35
Research and development reimbursements	$ 24	$ 15	$ 57	$ 40
Minimum
SIGNIFICANT ACCOUNTING POLICIES
Trade accounts receivable term			30 days
Maximum
SIGNIFICANT ACCOUNTING POLICIES
Trade accounts receivable term			60 days

SIGNIFICANT ACCOUNTING POLICI_5

SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of cash, cash equivalents and restricted cash (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022	Oct. 01, 2022	Dec. 31, 2021
SIGNIFICANT ACCOUNTING POLICIES
Cash	$ 60	$ 188
Short term deposits	115	285
Money market funds	1,018	551
Restricted cash (within other current and other long-term assets)	14	11
Cash, cash equivalents and restricted cash	$ 1,207	$ 1,035	$ 882	$ 625
Restricted cash, noncurrent, Statement of Financial Position [Extensible Enumeration]	Other long-term assets

SIGNIFICANT ACCOUNTING POLICI_6

SIGNIFICANT ACCOUNTING POLICIES - Notional amount and fair value of derivatives outstanding at Intel on behalf of Mobileye (Details) $ in Millions	Dec. 31, 2022 USD ($)
SIGNIFICANT ACCOUNTING POLICIES
Notional amount of derivatives	$ 93
Fair value of derivatives receivable from (payable to) Intel	$ (9)

SIGNIFICANT ACCOUNTING POLICI_7

SIGNIFICANT ACCOUNTING POLICIES - Change in accumulated other comprehensive income (loss) relating to gains (losses) on derivatives used for hedging (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022
SIGNIFICANT ACCOUNTING POLICIES
Other comprehensive income (loss) before reclassifications	$ 1		$ (30)
Amounts reclassified out of accumulated other comprehensive income (loss)	6	$ 10	6
Tax effects	(1)	(1)	1
Other comprehensive income (loss), net	$ 6	$ 9	$ (23)

OTHER FINANCIAL STATEMENT DET_3

OTHER FINANCIAL STATEMENT DETAILS - Inventories (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
OTHER FINANCIAL STATEMENT DETAILS
Raw materials	$ 52	$ 41
Work in process	2
Finished goods	300	72
Total inventories	$ 354	$ 113

OTHER FINANCIAL STATEMENT DET_4

OTHER FINANCIAL STATEMENT DETAILS - Property and equipment, net (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022	Dec. 31, 2022
Property and equipment, net
Total property and equipment, gross	$ 531		$ 531		$ 465
Less: accumulated depreciation	(105)		(105)		(81)
Total property and equipment, net	426		426		384
Depreciation expenses	9	$ 7	24	$ 17
Computers, electronic equipment and software
Property and equipment, net
Total property and equipment, gross	148		148		124
Vehicles
Property and equipment, net
Total property and equipment, gross	14		14		13
Office furniture and equipment
Property and equipment, net
Total property and equipment, gross	4		4		4
Leasehold improvements
Property and equipment, net
Total property and equipment, gross	42		42		22
Construction on process
Property and equipment, net
Total property and equipment, gross	$ 323		$ 323		$ 302

EQUITY - Stock-based compensati

EQUITY - Stock-based compensation plans (Details)	9 Months Ended
EQUITY - Stock-based compensation plans (Details)	Sep. 30, 2023
EQUITY
Service period	3 years

EQUITY - RSU activity (Details)

EQUITY - RSU activity (Details) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2023 USD ($) $ / shares shares	Sep. 30, 2023 USD ($) $ / shares shares
Number of RSUs
Outstanding at beginning \| shares	9,354
Granted \| shares	5,524
Vested \| shares	(2)
Forfeited \| shares	(114)
Outstanding at ending \| shares	14,762	14,762
Weighted average grant date fair value
Outstanding at beginning \| $ / shares	$ 22.2
Granted \| $ / shares	40.4
Vested \| $ / shares	35.1
Forfeited \| $ / shares	26.7
Outstanding at ending \| $ / shares	$ 29	$ 29
Unrecognized compensation cost \| $	$ 327	$ 327
weighted average period	2 years 4 months 24 days
RSUs
Number of RSUs
Outstanding at beginning \| shares		12,564
Granted \| shares		6,180
Vested \| shares		(3,752)
Forfeited \| shares		(230)
Outstanding at ending \| shares	14,762	14,762
Weighted average grant date fair value
Outstanding at beginning \| $ / shares		$ 21
Granted \| $ / shares		40.2
Vested \| $ / shares		21
Forfeited \| $ / shares		24.4
Outstanding at ending \| $ / shares	$ 29	$ 29
Intel 2006 Plan
Weighted average grant date fair value
Unrecognized compensation cost \| $	$ 108	$ 108
weighted average period		1 year 1 month 6 days
Intel 2006 Plan \| RSUs
Number of RSUs
Outstanding at beginning \| shares	4,848	5,692
Vested \| shares	(178)	(881)
Forfeited \| shares	(75)	(216)
Outstanding at ending \| shares	4,595	4,595
Weighted average grant date fair value
Outstanding at beginning \| $ / shares	$ 44.5	$ 44.8
Vested \| $ / shares	40.7	45.5
Forfeited \| $ / shares	45	45.7
Outstanding at ending \| $ / shares	$ 44.6	$ 44.6

EQUITY - Outstanding and exerci

EQUITY - Outstanding and exercisable options (Details) - $ / shares shares in Thousands		3 Months Ended	9 Months Ended	12 Months Ended
	Jul. 01, 2023	Sep. 30, 2023	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2017
EQUITY
Outstanding, Number of options	2,252	148	148	2,270
Outstanding, Weighted average remaining contractual life (In years)	4 months 24 days	3 years 6 months	3 years 6 months	9 months 18 days
Outstanding, Weighted average exercise price	$ 27.1	$ 30.9	$ 30.9	$ 27.1
Exercisable, Number of options		141	141
Exercisable, Weighted average exercise price		$ 31.4	$ 31.4
Intel's plan
EQUITY
Vesting period					3 years
Outstanding, Number of options		148	148
Outstanding, Weighted average remaining contractual life (In years)			3 years 6 months
Outstanding, Weighted average exercise price		$ 30.9	$ 30.9
Exercisable, Number of options		141	141
Exercisable, Weighted average exercise price		$ 31.4	$ 31.4
$ 4.0 - 21.6 \| Intel's plan
EQUITY
Exercise price, minimum			4
Exercise price, maximum			$ 21.6
Outstanding, Number of options		59	59
Outstanding, Weighted average remaining contractual life (In years)			2 years 3 months 18 days
Outstanding, Weighted average exercise price		$ 6.2	$ 6.2
Exercisable, Number of options		52	52
Exercisable, Weighted average exercise price		$ 4.1	$ 4.1
$ 22.4 - 24.3 \| Intel's plan
EQUITY
Exercise price, minimum			22.4
Exercise price, maximum			$ 24.3
Outstanding, Number of options		21	21
Outstanding, Weighted average remaining contractual life (In years)			3 months 18 days
Outstanding, Weighted average exercise price		$ 22.9	$ 22.9
Exercisable, Number of options		21	21
Exercisable, Weighted average exercise price		$ 22.9	$ 22.9
$55.2 \| Intel's plan
EQUITY
Exercise price			$ 55.2
Outstanding, Number of options		68	68
Outstanding, Weighted average remaining contractual life (In years)			5 years 6 months
Outstanding, Weighted average exercise price		$ 55.2	$ 55.2
Exercisable, Number of options		68	68
Exercisable, Weighted average exercise price		$ 55.2	$ 55.2

EQUITY - Option activity (Detai

EQUITY - Option activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions		3 Months Ended	9 Months Ended	12 Months Ended
	Jul. 01, 2023	Sep. 30, 2023	Sep. 30, 2023	Dec. 31, 2022
Number of options
Options outstanding at beginning		2,252	2,270
Exercised		(5)	(23)
Expired		(2,099)	(2,099)
Options outstanding at ending	2,252	148	148	2,270
Exercisable, Number of options		141	141
Weighted average remaining contractual Life
Outstanding, Weighted average remaining contractual life (In years)	4 months 24 days	3 years 6 months	3 years 6 months	9 months 18 days
Options exercisable		3 years 7 months 6 days	3 years 7 months 6 days
Weighted average exercise price
Options outstanding at beginning		$ 27.1	$ 27.1
Exercised		21.9	22.2
Expired		26.9	26.9
Options outstanding at ending	$ 27.1	30.9	30.9	$ 27.1
Exercisable, Weighted average exercise price		$ 31.4	$ 31.4
Aggregated intrinsic value
Options outstanding	$ 16	$ 2	$ 2	$ 1
Options exercisable		$ 2	$ 2
Share price		$ 35.6	$ 35.6
Number of options expected to vest		7	7
Average weighted exercise price of options expected to vest		$ 21.6	$ 21.6

EQUITY - Share-based compensati

EQUITY - Share-based compensation expense summary (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022
EQUITY
Total share-based compensation	$ 63	$ 36	$ 190	$ 112
Cost of revenue
EQUITY
Total share-based compensation	0		2
Research and development, net
EQUITY
Total share-based compensation	53	32	158	101
Sales and marketing
EQUITY
Total share-based compensation	2	1	6	3
General and administrative
EQUITY
Total share-based compensation	$ 8	$ 3	$ 24	$ 8

EARNINGS (LOSS) PER SHARE (Deta

EARNINGS (LOSS) PER SHARE (Details) - USD ($) $ / shares in Units, $ in Millions				3 Months Ended				9 Months Ended
	Jun. 12, 2023	Nov. 01, 2022	Oct. 28, 2022	Sep. 30, 2023		Oct. 01, 2022		Sep. 30, 2023		Oct. 01, 2022	[1]	Oct. 01, 2022	Dec. 31, 2022
EARNINGS (LOSS) PER SHARE
Number of shares issued				100,000,000				100,000,000
Par value (in dollars per share)				$ 0.01				$ 0.01
Number of shares outstanding				100,000,000				100,000,000
Dilutive effect of equity incentive awards				5,500,000				14,900,000
Numerator:
Net income (loss)				$ 17	[1]	$ (45)	[1]	$ (90)	[1]	$ (112)		$ (112)
Denominator:
Weighted average common shares - basic				806,000,000		750,000,000		804,000,000				750,000,000
Dilutive effect of unvested RSU awards				4,000,000
Weighted average common shares - diluted				810,000,000		750,000,000		804,000,000				750,000,000
Basic				$ 0.02		$ (0.06)		$ (0.11)				$ (0.15)
Diluted				$ 0.02		$ (0.06)		$ (0.11)				$ (0.15)
Class B common stock
EARNINGS (LOSS) PER SHARE
Number of shares issued				711,500,000				711,500,000					750,000,000
Par value (in dollars per share)				$ 0.01				$ 0.01					$ 0.01
Number of shares outstanding				711,500,000				711,500,000					750,000,000
Number of shares converted into Class A common stock	38,500,000
Class B common stock \| Cyclops holdings corporation
EARNINGS (LOSS) PER SHARE
Number of shares outstanding				750,000,000				750,000,000
Number of shares issued during the period								749,999,900
Class A common stock
EARNINGS (LOSS) PER SHARE
Number of shares issued				94,164,300				94,164,300					51,911,905
Par value (in dollars per share)				$ 0.01				$ 0.01					$ 0.01
Number of shares outstanding				94,164,300				94,164,300					51,911,905
Number of shares issued during the period		6,150,000
IPO \| Class B common stock
EARNINGS (LOSS) PER SHARE
Number of shares issued				100,000,000				100,000,000
IPO \| Class A common stock
EARNINGS (LOSS) PER SHARE
Number of shares issued during the period			41,000,000
Offering price per share			$ 21
Private placement \| Class A common stock
EARNINGS (LOSS) PER SHARE
Number of shares issued during the period			4,761,905
Offering price per share			$ 21
Over allotment option \| Class A common stock
EARNINGS (LOSS) PER SHARE
Number of shares issued during the period		6,150,000

[1]Rounding of Class A and Class B share amounts due to Secondary offering.

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
INCOME TAXES (Details) - USD ($) $ in Millions	Oct. 01, 2022	Oct. 01, 2022
INCOME TAXES
Amount payable under tax sharing agreement	$ 9	$ 16
Withholding tax expenses		$ 14

RELATED PARTY TRANSACTIONS - Ad

RELATED PARTY TRANSACTIONS - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022	Dec. 31, 2022	Dec. 31, 2022
RELATED PARTIES TRANSACTIONS
Leasing costs	$ 1.2	$ 1.3	$ 3.6	$ 2
Travel reimbursements cost	0.5	0.5	1.7	0.8
Amount payable under tax sharing agreement		9		16
Intel
RELATED PARTIES TRANSACTIONS
Amount payable under tax sharing agreement			34		$ 34
Stock Compensation Recharge Agreement
RELATED PARTIES TRANSACTIONS
Related party payable	1		1		$ 1	$ 1
Adjustment to additional paid-in capital for reimbursement amount	7	$ 5	29	$ 45
Administrative Services Agreement
RELATED PARTIES TRANSACTIONS
Costs incurred	1.7		2.9
Technology and Services Agreement
RELATED PARTIES TRANSACTIONS
Costs incurred	1.4		3.8
LiDAR Product Collaboration Agreement
RELATED PARTIES TRANSACTIONS
Lidar sensor system development costs						40
LiDAR Product Collaboration Agreement \| Intel
RELATED PARTIES TRANSACTIONS
Lidar sensor system development costs						$ 20
Amount received or receivable	$ 0		$ 0

IDENTIFIED INTANGIBLE ASSETS -

IDENTIFIED INTANGIBLE ASSETS - Components (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
IDENTIFIED INTANGIBLE ASSETS
Gross Assets	$ 4,491	$ 4,759
Accumulated Amortization	2,326	2,232
Net	2,165	2,527
Developed technology
IDENTIFIED INTANGIBLE ASSETS
Gross Assets	3,705	3,973
Accumulated Amortization	1,913	1,870
Net	1,792	2,103
Customer relationships & brands
IDENTIFIED INTANGIBLE ASSETS
Gross Assets	786	786
Accumulated Amortization	413	362
Net	$ 373	$ 424

IDENTIFIED INTANGIBLE ASSETS _2

IDENTIFIED INTANGIBLE ASSETS - Amortization expenses and weighted average useful lives (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022
IDENTIFIED INTANGIBLE ASSETS
Total amortization expenses	$ 111	$ 131	$ 362	$ 413
Developed technology
IDENTIFIED INTANGIBLE ASSETS
Amortization of intangible assets	94	115	$ 311	355
Developed technology \| Weighted Average Useful Life
IDENTIFIED INTANGIBLE ASSETS
Useful Life			10 years
Customer relationships & brands
IDENTIFIED INTANGIBLE ASSETS
Amortization of intangible assets	$ 17	$ 16	$ 51	$ 58
Customer relationships & brands \| Weighted Average Useful Life
IDENTIFIED INTANGIBLE ASSETS
Useful Life			12 years

IDENTIFIED INTANGIBLE ASSETS _3

IDENTIFIED INTANGIBLE ASSETS - Future amortization expenses (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
IDENTIFIED INTANGIBLE ASSETS
2023	$ 112
2024	445
2025	443
2026	332
2027	179
Thereafter	654
Total	$ 2,165	$ 2,527

SEGMENT INFORMATION (Details)

SEGMENT INFORMATION (Details)	9 Months Ended
SEGMENT INFORMATION (Details)	Sep. 30, 2023 segment
SEGMENT INFORMATION
Number of operating segments	2

SEGMENT INFORMATION - Segment r

SEGMENT INFORMATION - Segment results (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022
SEGMENT INFORMATION
Revenues	$ 530	$ 450	$ 1,442	$ 1,304
Cost of revenues	258	233	739	682
Research and development, net	218	206	664	565
Sales and Marketing	28	27	90	91
General and administrative	18	9	55	27
Operating income (loss)	8	(25)	(106)	(61)
Interest income (expense) with a related party, net		(6)		(11)
Other financial income (expense), net	15	1	38	6
Income (loss) before taxes on income	23	(30)	(68)	(66)
Share-based compensation	63	36	190	112
Depreciation of property and equipment	9	7	24	17
Operating Segments \| Mobileye
SEGMENT INFORMATION
Revenues	521	443	1,417	1,286
Cost of revenues	163	117	424	324
Research and development, net	208	196	633	534
Sales and Marketing	8	8	30	24
General and administrative	15	5	47	14
Operating income (loss)	127	117	283	390
Share-based compensation	59	32	175	101
Depreciation of property and equipment	9	7	24	17
Operating Segments \| Other
SEGMENT INFORMATION
Revenues	9	7	25	18
Cost of revenues	1	1	4	3
Research and development, net	10	10	31	31
Sales and Marketing	3	3	9	9
General and administrative	3	3	8	9
Operating income (loss)	(8)	(10)	(27)	(34)
Share-based compensation	4	4	15	11
Amounts not allocated to segments
SEGMENT INFORMATION
Cost of revenues	94	115	311	355
Sales and Marketing	17	16	51	58
General and administrative		1		4
Operating income (loss)	$ (111)	$ (132)	$ (362)	$ (417)

SEGMENT INFORMATION - Total rev

SEGMENT INFORMATION - Total revenues based on the country (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022
SEGMENT INFORMATION
Revenue	$ 530	$ 450	$ 1,442	$ 1,304
Product concentration \| Revenue \| EyeQ SoC
SEGMENT INFORMATION
Concentration risk percentage	89%	88%	90%	90%
China
SEGMENT INFORMATION
Revenue	$ 154	$ 126	$ 423	$ 360
USA
SEGMENT INFORMATION
Revenue	122	113	295	342
Germany
SEGMENT INFORMATION
Revenue	98	72	267	174
South Korea
SEGMENT INFORMATION
Revenue	37	31	118	86
United Kingdom
SEGMENT INFORMATION
Revenue	31	52	108	165
Poland
SEGMENT INFORMATION
Revenue	22	14	64	58
Czech Republic
SEGMENT INFORMATION
Revenue	11		41
Hungary
SEGMENT INFORMATION
Revenue	30	25	64	62
Rest of World
SEGMENT INFORMATION
Revenue	$ 25	$ 17	$ 62	$ 57

SEGMENT INFORMATION - Revenue f

SEGMENT INFORMATION - Revenue from major customers (Details) - Revenue - Customer Concentration	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Sep. 30, 2023	Oct. 01, 2022
Customer A
SEGMENT INFORMATION
Concentration risk percentage	27%	31%	28%	39%
Customer B
SEGMENT INFORMATION
Concentration risk percentage	26%	19%	26%	17%
Customer C
SEGMENT INFORMATION
Concentration risk percentage	15%	16%	14%	15%

SEGMENT INFORMATION - Accounts

SEGMENT INFORMATION - Accounts receivable balances of major customers (Details) - Accounts Receivable - Credit Concentration Risk	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Customer A
SEGMENT INFORMATION
Concentration risk percentage	32%	32%
Customer B
SEGMENT INFORMATION
Concentration risk percentage	16%	19%
Customer C
SEGMENT INFORMATION
Concentration risk percentage	22%	25%

SUBSEQUENT EVENTS - Equity Ince

SUBSEQUENT EVENTS - Equity Incentive Plan (Details) - USD ($) shares in Thousands, $ in Millions	1 Months Ended	9 Months Ended
	Oct. 31, 2023	Sep. 30, 2023
SUBSEQUENT EVENTS
Service period		3 years
Subsequent Events \| RSUs
SUBSEQUENT EVENTS
Aggregate value of shares issuable upon vesting of restricted stock units	$ 20.8
Granted shares	582
Service period	3 years